We report the case of a 63-year-old Moroccan male with Guillain-Barré syndrome (GBS) who, following treatment with intravenous immunoglobulin (IVIg), developed false-positive anti-HBs and anti-HBc antibodies. Here, KRT88P is linked to Guillain-Barre syndrome.